Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stress Neuromodulators in Decision Making
NCT04359147Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of yohimbine and hydrocortisone (4 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoints: Risk and loss-aversion, choice consistency at 45 minutes, Patch-leaving times at 45 minutes and 2 more. Started Nov 2019; status: completed.
02
Drugs
yohimbinehydrocortisone
Beyond the preview
Go deeper on NCT04359147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04359147.